Skip to main content
SpringerLink
Log in

Haben Sulfonamide noch ihren Platz in der Dermatotherapie?

  • Aktueller Kommentar
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Breneman DL, Ariano MC (1993) Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion. Int J Dermatol 32:365–367

    Article  CAS  PubMed  Google Scholar 

  2. Gloor M, Thoma K, Flur J (2000) Dermatologische Externatherapie.Unter besonderer Berücksichtigung der Magistralrezeptur. Springer, Berlin Heidelberg New York Tokyo, S 1–469

    Book  Google Scholar 

  3. Höger PH (1998) Topische Antibiotika und Antiseptika.Agentien, Spektren, Nebenwirkungen. Hautarzt 49:331–347

    Article  PubMed  Google Scholar 

  4. Bundesgesundheitsamt-Kommission-B-6 (1991) Bekanntmachung über die Zulassung und Registrierung von Arzneimitteln.Aufbereitungsmonographien der Kommission B 6. Sulfacetamid, Sulfadicramid, Sulfisomidin. Pharm Ztg 136:2250–2251

    Google Scholar 

  5. Bundesgesundheitsamt-Kommission-B-6 (1990) Bekanntmachung über die Zulassung und Registrierung von Arzneimitteln.Aufbereitungsmonographien der Kommission B 6. Sulfadimidin, Sulfaguanidin, Sulfamerazin. Pharm Ztg 135:827–828

    Google Scholar 

  6. Fischer H, Reimann H (2000) Sulfonamide nicht auf die Haut. Pharm Ztg 145:2304

    Google Scholar 

  7. Simon C, Stille W (1993) Antibiotika-Therapie in Klinik und Praxis, 8. Aufl. Schattauer, Stuttgart

    Google Scholar 

  8. Korting HC, Abeck D, Grimm W, Schiller Y (1990) Heutige In-vitro-Empfindlichkeit von Hautbakterien gegenüber unterschiedlichen Chemotherapeutika. Quantitative Ergebnisse des Mikrodilutionstests. Akt Dermatol 16:27–31

    Google Scholar 

  9. Huovinen P, Sundström L, Swedberg G, Sköld O (1995) Trimethoprim and sulfonamide resistance. Antimicrob Ag Chemother 39:279–289

    Article  CAS  Google Scholar 

  10. Mockenhaupt M, Schöpf E (1996) Epidemiology of drug-induced severe skin reactions. Semin Cutan Med Surg 15:236–243

    Article  CAS  PubMed  Google Scholar 

  11. Margolis DJ, Bondi EE (1990) Toxic epidermal necrolysis associated with sulfonamides. Int J Dermatol 29:153

    Article  CAS  PubMed  Google Scholar 

  12. N.N. (1971) Mafenide acetate cream: a review. Drugs 1:434–460

    Article  Google Scholar 

  13. Breit R, Seifert P (1989) Mafenide — still an allergen of importance? In: Frosch PJ, Dooms-Goossens A, Lachapelle JM, Rycroft RJG, Scheper RJ (eds) Current topics in contact dermatitis. Springer, Berlin Heidelberg, New York Tokyo, pp 222–225

    Chapter  Google Scholar 

  14. Enders F, Przybilla B, Ring J, Burg G, Braun-Falco O (1988) Epikutantestung mit einer Standardreihe — Ergebnisse bei 12.026 Patienten.Hautarzt 39:779-78

    CAS  PubMed  Google Scholar 

  15. Enders F,Przybilla B,Ring J, Gollhausen R (1989) Patch test results in 1987 compared to trends from the period 1977-1983}. Contact Dermat 20:230–232

    Article  CAS  Google Scholar 

  16. Scheuer B, Rüther T, v.Bülow V et al. (1992) Häufige Kontaktallergene — Eine praxisorientierte Multicenterstudie. Akt Dermatol 18:44–49

    Google Scholar 

  17. Fernandez JC, Gamboa P, Jauregui I, Gonzalez G, Antepara I (1992) Concomitant sensitization to enoxolone and mafenide in a topical medicament. Contact Dermat 27:262

    Article  CAS  Google Scholar 

  18. Sanz-de-Galdeano C, Aguirre A, Oleaga JM, Goday J, Diaz-Perez JL (1993) Allergic contact dermatitis from topical mafenide. Contact Dermat 28:249

    Article  CAS  Google Scholar 

  19. Rudzki E, Rebandel P (1987) Primary sensitivity to sulphonamide and secondary sensitization to aromatic amines. Contact Dermat 17:49

    Article  CAS  Google Scholar 

  20. Angelini G, Meneghini CL (1981) Oral tests in contact allergy to para-amino compounds. Contact Dermat 7:311–314

    Article  CAS  Google Scholar 

  21. Uter W, Geier J, Fuchs T, Richter G (2001) Das Epikutantest-Screening mit „Parastoffen”. Dermatol Beruf Umwelt 49:42

    Google Scholar 

  22. Valsecchi R, Foiadelli L, Cainelli T (1986) Is silver sulfadiazine a sensitizer? Contact Dermat 15:45

    Article  Google Scholar 

  23. Kleniewska D, Maibach H (1980) Allergenicity of aminobenzene compounds: structurefunction relationships. Derm Beruf Umwelt 28:11–13

    CAS  PubMed  Google Scholar 

  24. Basketter DA, Scholes EW, Cumberbatch M, Evans CD, Kimber I (1992) Sulphanilic acid: divergent results in the guinea pig maximization test and the local lymph node assay. Contact Dermat 27:209–213

    Article  CAS  Google Scholar 

  25. Lepoittevin JP, Basketter DA, Goossens A, Karlberg AT (1998) Allergic contact dermatitis. The molecular basis. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  26. Editorial (1978) Antibiotic resistance and topical treatment. Br Med J I:649–650

    Google Scholar 

  27. Richet H, Andre-Richet B, Le Gallou Fl (2001) Que penser des resistances bacteriennes dans l'acne? Ann Dermatol Venereol 128:2S15–2S17

    Google Scholar 

  28. Simpson N (2001) Antibiotics in acne: time for a rethink.Editorial. Br J Dermatol 144:225–227

    Article  CAS  PubMed  Google Scholar 

  29. Grumbach A, Hegglin R (1942) Klinischbakteriologische Untersuchungen über die Sulfonamid-Resistenz der Pneumokokken. Schweiz Med Wochenschr 72:1369–1376

    CAS  Google Scholar 

  30. Mandell GL, Sande MA (1980) Antimicrobial agents: sulfonamides, trimethoprim-sulfamethoxazole, and urinary tract antiseptics. In: Goodman Gilman A, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Macmillan Publishing, New York, pp 1106–1125

    Google Scholar 

  31. Brumfitt W, Hamilton-Miller JM (1995) Combinations of sulphonamides with diaminopyrimidines: how,when and why? J Chemother 7:136–139

    Article  CAS  PubMed  Google Scholar 

  32. Lane MR, Allan RN, Pease PE (1988) Antibiotic resistance in Escherichia coli from patients on sulphasalazine. Lancet I (No.8599):1403–1404

    Article  Google Scholar 

  33. Whitney CG, Farley MM, Hadler J et al. (2000) Increasing prevalence of multidrug-resistant streptococcus peumoniae in the United States. N Engl J Med 343:1917–1924

    Article  CAS  PubMed  Google Scholar 

  34. Krummel T, Dimitrov Y, Moulin B, Hannedouche T (2000) Drug points: acute renal failure induced by topical ketoprofen. Br Med J 320:93

    Article  CAS  Google Scholar 

  35. Schmidt KU, Wagner G, Mensing H (1987) Östrogen-induzierte Gynäkomastie nach Anwendung östrogenhaltiger Lokaltherapeutika. Dtsch Med Wochenschr 112:926–928

    Article  CAS  PubMed  Google Scholar 

  36. Miller YW, Eady EA, Lacey RW, Cove JH, Joanes DN, Cunliffe WJ (1996) Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 38:829–837

    Article  CAS  PubMed  Google Scholar 

  37. Enne V, Livermore DM, Stephens P, Hall LMC (2001) Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357:1325–1328

    Article  CAS  PubMed  Google Scholar 

  38. Cunha BA (2001) SEffective antibiotic-resistance control strategies.Commentary. Lancet 357:1307–1308

    Article  CAS  PubMed  Google Scholar 

  39. Ravenscroft JC, Layton A, Barnham M (2000) Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 25:327–330

    Article  CAS  PubMed  Google Scholar 

  40. Wallmann J (1999) Antibakterielle Chemotherapie unter dem Aspekt der Antibiotikaresistenz. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschuz 42:58–61

    Article  Google Scholar 

  41. McDonnell G, Denver Russell A (1999) Antiseptics and desinfectants: activity, action, and resistance. Clin Microbiol Rev 12:147–179

    CAS  PubMed Central  PubMed  Google Scholar 

  42. N.N. (2001) Keine Leistungspflicht der GKV für Altarzneimittel ohne Nachzulassung. Arzneitelegramm 32:103

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IVDK/Universitäts-Hautklinik, von Siebold Straße 3, 37075, Göttingen, Germany

    A. Schnuch

Authors
  1. A. Schnuch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Schnuch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schnuch, A. Haben Sulfonamide noch ihren Platz in der Dermatotherapie?. Hautarzt 53, 163–166 (2002). https://doi.org/10.1007/s00105-001-0322-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-001-0322-8

Search

Navigation